A Silicon Valley start-up with some big-name backers is offering a test on a sample of saliva for breast and ovarian cancer that is so inexpensive that most women could get it. New York Times, 04/21/2015. (Also see Cancer)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.